http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102762199-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
filingDate 2011-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102762199-B
titleOfInvention Comprise the oral complex composition of pseudoephedrine and levocetirizine
abstract The invention provides a kind of oral complex composition, comprise (i) core, it comprises expandable hydrogel forming agent and pseudoephedrine or its pharmaceutical salts; (ii) wrap up the first coatings of described core, it comprises water-soluble substances; (iii) be deposited on the second coatings in described first coatings, it comprises levocetirizine or its pharmaceutical salts and polyvinyl alcohol, polyvidone, polyvinyl alcohol-polyethyleneglycol-graft copolymer or its mixture, described oral complex composition have raising levocetirizine rate of release and after long storage periods also non-display delay release behavior.Therefore, oral complex composition of the present invention can be used for treating comprise nasal obstruction, sneeze and rhinorrhea perennially or seasonal anaphylactic disease.
priorityDate 2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6171618-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7028
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID200487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447768971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43833360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410437627
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID200487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131752735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451693611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137849

Total number of triples: 35.